SPIA
INTS icon

Steward Partners Investment Advisory’s Intensity Therapeutics INTS Stock Holding History

Steward Partners Investment Advisory’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36
Closed -$4.41K – 3800
2024
Q2 		$4.41K Buy
+36
New +$4.08K ﹤0.01% 3082

Other funds holding INTS

SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
OCPWS
One Charles Private Wealth Services Hingham, Massachusetts $434M AUM 22.37% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Steward Partners Investment Advisory's INTS Position: Q3 2024 in Review

Steward Partners Investment Advisory sold out of Intensity Therapeutics (INTS) in Q3 2024, closing a stake of 36 shares — an estimated $4.41K sold.

Steward Partners Investment Advisory first reported a position in INTS in Q2 2024 and held it in 1 quarter. The position peaked at $4.41K in Q2 2024. 20 funds tracked by Wall St. Rank hold INTS as of Q3 2024.

  • Steward Partners Investment Advisory reported no remaining Intensity Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 36 Intensity Therapeutics shares in Q3 2024, an estimated $4.41K.
  • Steward Partners Investment Advisory first reported a position in Intensity Therapeutics in Q2 2024 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Intensity Therapeutics position peaked at $4.41K in Q2 2024.
  • 20 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q3 2024.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2024, filed 14 Nov 2024.